fbpx
QQQ
+ 2.15
345.59
+ 0.62%
DIA
+ 3.22
335.56
+ 0.95%
SPY
+ 2.53
420.07
+ 0.6%
TLT
+ 0.23
143.04
+ 0.16%
GLD
-0.11
166.25
-0.07%

PRX, ALKS, Initiated At Buy

by
September 30, 2010 10:23 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

UBS has initiated coverage for the following companies:

Par Pharmaceutical Companies (NYSE: PRX) Buy, $35 price target

Alkermes Inc. (NASDAQ: ALKS) Buy, $18 price target

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

Benzinga's Top Upgrades, Downgrades For December 19, 2018

Benzinga's Top Upgrades, Downgrades For August 7, 2018

Benzinga's Top Upgrades, Downgrades For June 21, 2018

4 SMID-Cap Biotechs Barclays Just Confessed It Loves